CIBC World Markets’s Repligen RGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
– Sell
-2,857
Closed -$360K – 740
2024
Q2
$360K Buy
2,857
+685
+32% +$107K ﹤0.01% 685
2024
Q1
$399K Buy
2,172
+696
+47% +$133K ﹤0.01% 747
2023
Q4
$265K Buy
+1,476
New +$230K ﹤0.01% 714
2021
Q2
– Sell
-5,469
Closed -$1.06M – 876
2021
Q1
$1.06M Buy
+5,469
New +$1.12M 0.01% 593

Other funds holding RGEN

CIBC World Markets's RGEN Position: Q3 2024 in Review

CIBC World Markets sold out of Repligen (RGEN) in Q3 2024, closing a stake of 2,857 shares — an estimated $360K sold.

CIBC World Markets first reported a position in RGEN in Q1 2021 and held it in 4 quarters. The position peaked at $1.06M in Q1 2021. 444 funds tracked by Wall St. Rank hold RGEN as of Q3 2024.

  • CIBC World Markets reported no remaining Repligen position as of Q3 2024 after selling out during the quarter.
  • CIBC World Markets sold 2,857 Repligen shares in Q3 2024, an estimated $360K.
  • CIBC World Markets first reported a position in Repligen in Q1 2021 and held it in 4 quarters.
  • CIBC World Markets's Repligen position peaked at $1.06M in Q1 2021.
  • 444 funds tracked by Wall St. Rank held Repligen as of Q3 2024.

Based on CIBC World Markets's 13F filing for Q3 2024, filed 13 Nov 2024.